Manuel Sanchez-felix PhD

Dr Manuel Sanchez-Felix is a Senior Fellow with the Chemical and Pharmaceutical Profiling (CPP) group at the Novartis Institutes for BioMedical Research in Cambridge, MA. He is a scientific leader with over 20 years of experience in drug discovery and development where he co-invented products and contributed to the successful development and launch of various pharmaceutical products.

At Novartis, Dr Sanchez-Felix leads a cross-functional group from Discovery and Development that is responsible for Novel Delivery Technologies. His previous position at Novartis involved heading a group of scientists at the interface between Research and Development, establishing physicochemical and biopharmaceutical properties, and combining this information to initiate development strategy and formulation design.

Prior to joining Novartis, Dr Sanchez-Felix was at Eli Lilly & Company for 20 years. His area of expertise includes Biopharmaceutics, drug delivery and patient-centered formulation design. Areas of drug discovery were he has developed products include CNS, infectious diseases (specifically TB), oncology, bone regeneration, and diabetes.